Expression of Ret/PTCI, -2, -3, mA3 and m4 in German papillary thyroid carcinoma
1998

Expression of Ret/PTC in German Papillary Thyroid Carcinoma

Sample size: 99 publication Evidence: moderate

Author Information

Author(s): B Mayr, E Potter, P Goretzki, J Ruschoff, W Dietmaier, C Hoang-Vu, H Dralle, G Brabant

Primary Institution: Medizinische Hochschule Hannover

Hypothesis

What is the expression frequency of ret/PTC oncogene in German papillary thyroid carcinomas?

Conclusion

The study found that 8% of the examined German papillary thyroid carcinomas expressed the ret/PTC oncogene, but none showed the newly described variants.

Supporting Evidence

  • Eight ret/PTC-positive tumors were identified in the study.
  • The study examined 99 papillary thyroid carcinomas from various German institutions.
  • Previous studies reported a variable prevalence of ret/PTC from 2.5% to 30%.

Takeaway

The researchers looked at thyroid cancer samples and found that a small number had a specific gene change, but none had the new types of changes that were recently discovered.

Methodology

Tissue specimens were homogenized, RNA was extracted, and PCR was used to detect ret/PTC expression.

Limitations

The presence of ret/PTC2 cannot be excluded due to lack of a positive control.

Participant Demographics

German patients with papillary thyroid carcinoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication